Trial Profile

A pharmacokinetic study of the oral formulation of PL-8177

Status: Recruiting

Phase of Trial: Phase 0

Latest Information Update: 11 Apr 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PL 8177 (Primary)
Indications Ulcerative colitis
Focus Pharmacokinetics
Sponsors Palatin Technologies

Most Recent Events

04 Apr 2019 Primary endpoint has been met. (Release of polymer-bound PL-8177 in the lower gastrointestinal tract after oral administration)
04 Apr 2019 Positive top line results published in the Palatin Technologies Media Release
12 Feb 2019 according to a Palatin Technologies media release, this trial was started during the quarter ended December 31, 2018, with data expected in the first quarter of calendar year 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com